MedMira’s Multiplo multiplex tests include combination testing solutions for HIV-1/2, Hepatitis B and C, and Syphilis. MedMira is dedicated to improving human health by providing the best in rapid diagnostics. Our patented Rapid Vertical Flow Technology™ delivers fast, accurate results for a range of applications—helping care providers and their patients know more, instantly. Halifax, Nova Scotia, March 24, 2016 – MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the three and six month periods ended January 31, 2016. MORE › Halifax, Nova Scotia, March 3, 2016 – MedMira Inc. (MedMira) (TSXV: MIR) announced today that Dr. Martial Lacroix is stepping down from his role on the Company’s Board of Directors in order to fulfil other responsibilities that require unanticipated and significant time commitments. MORE › We heard first hand feedback and experiences from customers using Miriad to add a new layer of information to the donor eligibility screening process and increase staff safety in the field MORE › Source.